InChI=1S/C15H13NO3/c17- 14(10- 4- 2- 1- 3- 5- 10) 13- 7- 6- 12- 11(15(18) 19) 8- 9- 16(12) 13/h1- 7,11H,8- 9H2,(H,18,19) /t11- /m1/s1 |
OZWKMVRBQXNZKK-LLVKDONJSA-N |
OC(=O)[C@@H]1CCn2c1ccc2C(=O)c1ccccc1 |
|
Bronsted base
A molecular entity capable of accepting a hydron from a donor (Bronsted acid).
(via organic amino compound )
Bronsted acid
A molecular entity capable of donating a hydron to an acceptor (Bronsted base).
(via oxoacid )
|
|
analgesic
An agent capable of relieving pain without the loss of consciousness or without producing anaesthesia. In addition, analgesic is a role played by a compound which is exhibited by a capability to cause a reduction of pain symptoms.
|
|
analgesic
An agent capable of relieving pain without the loss of consciousness or without producing anaesthesia. In addition, analgesic is a role played by a compound which is exhibited by a capability to cause a reduction of pain symptoms.
|
|
View more via ChEBI Ontology
(1R)-5-benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid
|
(+)-ketorolac
|
ChemIDplus
|
(R)-(+)-ketorolac
|
ChEBI
|
6064295
|
Reaxys Registry Number
|
Reaxys
|
66635-93-6
|
CAS Registry Number
|
ChemIDplus
|
10027870
|
PubMed citation
|
Europe PMC
|
10223774
|
PubMed citation
|
Europe PMC
|
10593468
|
PubMed citation
|
Europe PMC
|
17456651
|
PubMed citation
|
Europe PMC
|
19281996
|
PubMed citation
|
Europe PMC
|
23447046
|
PubMed citation
|
Europe PMC
|
9549656
|
PubMed citation
|
Europe PMC
|
|